These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 31445926

  • 1. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
    Edmonston D, Wojdyla D, Mehta R, Cai X, Lora C, Cohen D, Townsend RR, He J, Go AS, Kusek J, Weir MR, Isakova T, Pencina M, Wolf M, CRIC Study Investigators.
    Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
    [Abstract] [Full Text] [Related]

  • 2. Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Mehta R, Cai X, Lee J, Xie D, Wang X, Scialla J, Anderson AH, Taliercio J, Dobre M, Chen J, Fischer M, Leonard M, Lash J, Hsu CY, de Boer IH, Feldman HI, Wolf M, Isakova T, CRIC Study Investigators.
    Am J Kidney Dis; 2020 Jun; 75(6):908-918. PubMed ID: 31864822
    [Abstract] [Full Text] [Related]

  • 3. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
    Alderson HV, Ritchie JP, Middleton R, Larsson A, Larsson TE, Kalra PA.
    Nephrology (Carlton); 2016 Jul; 21(7):566-73. PubMed ID: 27334353
    [Abstract] [Full Text] [Related]

  • 4. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, Anderson AH, Raj DS, Wolf M, CRIC Study Investigators.
    Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E, Thodis E, Arsos G, Pasadakis P, Panagoutsos S, Papadopoulou D, Papagianni A.
    Kidney Blood Press Res; 2020 Mar; 45(6):900-915. PubMed ID: 33040068
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Edmonston D, Fuchs MAA, Burke EJ, Isakova T, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.
    Am J Kidney Dis; 2024 Sep; 84(3):349-360.e1. PubMed ID: 38583756
    [Abstract] [Full Text] [Related]

  • 9. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV, Ritchie JP, Pagano S, Middleton RJ, Pruijm M, Vuilleumier N, Kalra PA.
    Clin J Am Soc Nephrol; 2016 Dec 07; 11(12):2141-2149. PubMed ID: 27852662
    [Abstract] [Full Text] [Related]

  • 10. Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.
    Deo R, Katz R, de Boer IH, Sotoodehnia N, Kestenbaum B, Mukamal KJ, Chonchol M, Sarnak MJ, Siscovick D, Shlipak MG, Ix JH.
    Am J Kidney Dis; 2015 Jul 07; 66(1):40-6. PubMed ID: 25572028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, Ojo A, Scialla J, Steigerwalt S, Teal V, Wolf M, Rahman M, CRIC Investigators.
    Am J Kidney Dis; 2013 Oct 07; 62(4):670-8. PubMed ID: 23489677
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W, Nessel L, Anderson AH, Lo J, Porter A, Nunes JW, Negrea L, Hamm L, Horwitz E, Chen J, Scialla JJ, de Boer IH, Leonard MB, Feldman HI, Wolf M, CRIC Study Investigators.
    Am J Kidney Dis; 2020 Feb 07; 75(2):235-244. PubMed ID: 31668375
    [Abstract] [Full Text] [Related]

  • 15. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.
    Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, Mifflin T, Waikar SS, Sabbisetti VS, Bonventre JV, Coresh J, Nelson RG, Kimmel PL, Kusek JW, Rahman M, Schelling JR, Vasan RS, Liu KD, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators, CKD Biomarkers Consortium.
    Clin J Am Soc Nephrol; 2017 May 08; 12(5):761-771. PubMed ID: 28254771
    [Abstract] [Full Text] [Related]

  • 16. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.
    Forsblom C, Moran J, Harjutsalo V, Loughman T, Wadén J, Tolonen N, Thorn L, Saraheimo M, Gordin D, Groop PH, Thomas MC, FinnDiane Study Group.
    Diabetes Care; 2014 Aug 08; 37(8):2334-42. PubMed ID: 24879837
    [Abstract] [Full Text] [Related]

  • 17. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Foster MC, Coresh J, Hsu CY, Xie D, Levey AS, Nelson RG, Eckfeldt JH, Vasan RS, Kimmel PL, Schelling J, Simonson M, Sondheimer JH, Anderson AH, Akkina S, Feldman HI, Kusek JW, Ojo AO, Inker LA, CKD Biomarker Consortium and the CRIC Study Investigators.
    Am J Kidney Dis; 2016 Jul 08; 68(1):68-76. PubMed ID: 26948990
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
    Amdur RL, Feldman HI, Dominic EA, Anderson AH, Beddhu S, Rahman M, Wolf M, Reilly M, Ojo A, Townsend RR, Go AS, He J, Xie D, Thompson S, Budoff M, Kasner S, Kimmel PL, Kusek JW, Raj DS, CRIC Study Investigators.
    Am J Kidney Dis; 2019 Mar 08; 73(3):344-353. PubMed ID: 30545708
    [Abstract] [Full Text] [Related]

  • 20. Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).
    Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Rifkin D, Siscovick DS, Sarnak MJ, Shlipak MG.
    J Am Coll Cardiol; 2012 Jul 17; 60(3):200-7. PubMed ID: 22703926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.